Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjects

BACKGROUND: Phosphodiesterase 4 (PDE4) inhibitors increase intracellular cyclic adenosine monophosphate (cAMP), leading to regulation of inflammatory cell functions. Roflumilast is a potent and targeted PDE4 inhibitor. The objective of this study was to evaluate the effects of roflumilast on broncho...

Descripción completa

Detalles Bibliográficos
Autores principales: Gauvreau, Gail M, Boulet, Louis-Philippe, Schmid-Wirlitsch, Christine, Côté, Johanne, Duong, MyLinh, Killian, Kieran J, Milot, Joanne, Deschesnes, Francine, Strinich, Tara, Watson, Richard M, Bredenbröker, Dirk, O'Byrne, Paul M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219708/
https://www.ncbi.nlm.nih.gov/pubmed/22029856
http://dx.doi.org/10.1186/1465-9921-12-140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219708/
https://www.ncbi.nlm.nih.gov/pubmed/22029856
http://dx.doi.org/10.1186/1465-9921-12-140

Ejemplares similares